Luminous
← All bills
HR 3029Passed HouseTech & Sciencehouse

To amend the Research and Development, Competition, and Innovation Act to support nucleic acid screening, and for other purposes.

Introduced Apr 28, 2025 by Rep. Andrea Salinas

IntroducedCommitteeFloorCongressLaw

The House passed it. The Senate has to pass it before it can reach the President.

Latest action · Jul 21, 2026
Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
Read it on Congress.gov
What it does

This bill explicitly requires the National Institute of Standards and Technology (NIST) to support the development of best practices and technical standards for nucleic acid synthesis.

Nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), carry genetic information within cells. Nucleic acid synthesis is the process of designing and creating custom nucleic acids; it is used in the development of medications and agricultural products. However, this technology also poses a risk of misuse (e.g., the intentional or unintentional creation of dangerous biological agents).

The bill requires NIST to carry out measurement research to support the development and improvement of biosecurity best practices and technical standards related to nucleic acid synthesis. This effort must address specified topics including nucleic acid synthesis screening, operational security, and conformity assessment. (A 2023 executive order titled Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence directed NIST to develop and refine similar specifications and best practices for use by synthetic nucleic acid providers. NIST's work on this topic is ongoing.)

In carrying out this effort, NIST must convene stakeholders to develop and periodically update consensus priorities and best practices for synthetic nucleic acid screening mechanisms. Within a specified period, NIST must submit a summary of the stakeholder group’s findings to Congress.

Read the full summary on Congress.gov

Summary by the Congressional Research Service.

Roll-call votes

No recorded roll-call vote on this bill — it may have passed by voice vote or unanimous consent, which don't record individual votes.

History
  1. Jul 21, 2026
    Received in the Senate and Read twice and referred to the Committee on Commerce, Science, and Transportation.
  2. Jul 20, 2026
    Motion to reconsider laid on the table Agreed to without objection.
  3. Jul 20, 2026
    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
  4. Jul 20, 2026
    Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H4666)
  5. Jul 20, 2026
    DEBATE - The House proceeded with forty minutes of debate on H.R. 3029.
  6. Jul 20, 2026
    Considered under suspension of the rules. (consideration: CR H4666-4667)
  7. Jul 20, 2026
    Mr. Babin moved to suspend the rules and pass the bill, as amended.
  8. Jul 16, 2026
    Placed on the Union Calendar, Calendar No. 654.
  9. Jul 16, 2026
    Reported by the Committee on Science, Space, and Technology. H. Rept. 119-751.
  10. Apr 29, 2025
    Ordered to be Reported by Voice Vote.
  11. Apr 29, 2025
    Committee Consideration and Mark-up Session Held
  12. Apr 28, 2025
    Referred to the House Committee on Science, Space, and Technology.
  13. Apr 28, 2025
    Introduced in House